MARKET

PACB

PACB

Pacific Biosc
NASDAQ
3.790
-0.120
-3.07%
Pre Market: 3.870 +0.08 +2.11% 04:08 03/18 EDT
OPEN
3.900
PREV CLOSE
3.910
HIGH
3.980
LOW
3.730
VOLUME
11
TURNOVER
0
52 WEEK HIGH
14.55
52 WEEK LOW
3.730
MARKET CAP
1.02B
P/E (TTM)
-3.1338
1D
5D
1M
3M
1Y
5Y
PacBio's (PACB) New Panel to Aid Its Clinical Research Solution
NASDAQ · 5d ago
Pacific Biosciences of California Becomes Oversold (PACB)
NASDAQ · 6d ago
How Is The Market Feeling About Pacific Biosciences?
Pacific Biosciences's short percent of float has risen 18.14% since its last report. The company has 40.38 million shares sold short. Short interest is the number of shares that have been sold short but have not yet been covered. Short selling is when a trader sells shares of a company in the hope the price will fall.
Benzinga · 6d ago
Weekly Report: what happened at PACB last week (0304-0308)?
Weekly Report · 03/11 09:28
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its weakness. Pacific Biosciences of California, Inc. Has an RSI near or below 30. The company's stock fell 27% over the past five days.
Benzinga · 03/07 12:18
Weekly Report: what happened at PACB last week (0226-0301)?
Weekly Report · 03/04 09:29
Illumina's Turnaround Play: Betting On NovaSeq X Amidst Rising Competitive Tides
Illumina operates in the genetic and genomic analysis sector. The company's strategic priorities include achieving top-line growth, improving operation efficiency and divesting GRAIL. Illumina's NovaSeq X platform has been successful, but the door is open to competition.
Seeking Alpha · 02/29 00:08
Weekly Report: what happened at PACB last week (0219-0223)?
Weekly Report · 02/26 09:32
More
About PACB
Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The Company has developed Single Molecule, Real-Time (SMRT) technology, which accurately detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid (DNA) molecules. The Company’s products include Revio, Sequel, Sequel II and Sequel IIe instruments that conduct, monitor, and analyze single-molecule biochemical reactions in real time. The instruments use extremely sensitive imaging systems to collect the light pulses emitted by fluorescent reagents allowing the observation of biological processes. Once sequencing is started, the real-time data is delivered to the system’s primary analysis pipeline, which outputs base identity and quality values.

Webull offers Pacific Biosciences of California Inc stock information, including NASDAQ: PACB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PACB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PACB stock methods without spending real money on the virtual paper trading platform.